Medicine & Life Sciences
Adenocarcinoma
100%
Pancreatic Neoplasms
98%
Survival
51%
pembrolizumab
46%
Neuroendocrine Tumors
37%
Drug Therapy
34%
Radiosurgery
30%
Neoplasms
25%
DNA Mismatch Repair
23%
gemcitabine
22%
Microsatellite Instability
20%
Irinotecan
19%
130-nm albumin-bound paclitaxel
19%
Progression-Free Survival
16%
GVAX vaccine
15%
Radiation
14%
Therapeutics
14%
Induction Chemotherapy
14%
Colorectal Neoplasms
14%
Pancreas
12%
Immunohistochemistry
12%
Biomarkers
12%
Endometrial Neoplasms
12%
Precision Medicine
11%
Microsatellite Repeats
11%
Recurrence
11%
Adjuvant Chemotherapy
11%
Confidence Intervals
11%
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
11%
guadecitabine
11%
Immunosuppression
10%
Disease-Free Survival
10%
Neoplastic Stem Cells
10%
Temozolomide
10%
HhAntag691
8%
Cyclophosphamide
8%
Tumor Microenvironment
8%
Deoxycytidine Kinase
8%
olaparib
8%
Turcot syndrome
8%
Response Evaluation Criteria in Solid Tumors
7%
p21-Activated Kinases
7%
Margins of Excision
7%
Adenosquamous Carcinoma
7%
Extranodal Extension
7%
Immunotherapy
7%
Radiation Oncology
7%
Hydroxychloroquine
7%
Carcinoma
7%
Fluorouracil
7%